Status:
COMPLETED
Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C, Chronic
Hepatitis C
Eligibility:
All Genders
18+ years
Brief Summary
Enrolled patients will be recruited to two parallel groups during therapy for Hepatitis C. Patients in the first one will receive a patient assistance program, and patients in the second group will no...
Detailed Description
Non-Probability Sample, Commercial product used according to EU label.
Eligibility Criteria
Inclusion
- According to PegIntron/Rebetol label.
- Only HCV genotype 1 infected patients will be enrolled in the study.
Exclusion
- According to PegIntron/Rebetol label.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00728494
Start Date
October 1 2005
End Date
December 1 2007
Last Update
July 28 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.